Hannah G. Rosenblum

Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021

Lyudmyla Kompaniyets, Audrey F. Pennington, Alyson B. Goodman et al. · Preventing Chronic Disease · 2021 · 364 citations · Full text

Public Health, Chronic Disease Prevention, Health Promotion +13

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

Hannah G. Rosenblum, Stephen C. Hadler, Danielle Moulia et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 214 citations · Full text

Medicine, Immunology, Infectious Diseases +17

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

Hannah G. Rosenblum, Julianne Gee, Ruiling Liu et al. · The Lancet Infectious Diseases · 2022 · 183 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021

Anne M. Hause, Julianne Gee, James Baggs et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 166 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

Hannah G. Rosenblum, Megan J. Wallace, Monica Godfrey et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 161 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17